TRCT
OPTR

Tower Research Capital (TRC)’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Tower Research Capital (TRC)’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,571
Closed -$20K – 5441
2013
Q3 		$20K Buy
+1,571
New +$20.8K ﹤0.01% 2712

Tower Research Capital (TRC)'s OPTR Position: Q4 2013 in Review

Tower Research Capital (TRC) sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 1,571 shares — an estimated $20K sold.

Tower Research Capital (TRC) first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $20K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Tower Research Capital (TRC) reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,571 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $20K.
  • Tower Research Capital (TRC) first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $20K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2013, filed 31 Jan 2014.